Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-29 @ 7:50 PM
Study NCT ID:
NCT04971551
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-06
First Post:
2021-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-19
First Submit QC Date:
None
Study First Post Date:
2021-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-04
Last Update Post Date:
2024-03-06
Last Update Post Date Type:
ACTUAL